AroCell’s TK 210 ELISA Blood Test is a Giant Leap towards Personalized Medicine for Cancer Patients
As defined by the U.S. President’s Council on Advisors on Science and Technology, “Personalized Medicine” refers to the tailoring of medical treatment to the individual characteristics of each patient… to classify individuals into subpopulations that differ in their susceptibility to a particular disease or their response to a specific treatment. Preventative or therapeutic interventions can then be concentrated on those who will benefit, sparing expense and side effects for those who will not.’’ ...